mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
0.03 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.9 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |